Drug Type Small molecule drug |
Synonyms NCATS-SM1440 |
Target |
Action inhibitors |
Mechanism L-lactate dehydrogenase inhibitors(L-lactate dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H22F2N4O4S3 |
InChIKeyWGFNHVCWSDXXPH-UHFFFAOYSA-N |
CAS Registry1964516-59-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 08 Oct 2020 |





